WO2008012476A3 - Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique - Google Patents

Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique Download PDF

Info

Publication number
WO2008012476A3
WO2008012476A3 PCT/FR2007/051732 FR2007051732W WO2008012476A3 WO 2008012476 A3 WO2008012476 A3 WO 2008012476A3 FR 2007051732 W FR2007051732 W FR 2007051732W WO 2008012476 A3 WO2008012476 A3 WO 2008012476A3
Authority
WO
WIPO (PCT)
Prior art keywords
carboxypeptidases
cosmetics
sequence
therapeutic field
acid sequence
Prior art date
Application number
PCT/FR2007/051732
Other languages
English (en)
Other versions
WO2008012476A2 (fr
Inventor
Caroline Delattre
Dominique Bernard
Original Assignee
Oreal
Caroline Delattre
Dominique Bernard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0653130A external-priority patent/FR2904223B1/fr
Application filed by Oreal, Caroline Delattre, Dominique Bernard filed Critical Oreal
Publication of WO2008012476A2 publication Critical patent/WO2008012476A2/fr
Publication of WO2008012476A3 publication Critical patent/WO2008012476A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/17—Metallocarboxypeptidases (3.4.17)
    • C12Y304/17001—Carboxypeptidase A (3.4.17.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne une composition cosmétique ou pharmaceutique, comprenant dans un milieu physiologiquement acceptable, au moins un polypeptide de séquence d'acides aminés codée par une séquence d'acides nucléiques représentée en tout ou partie par une séquence choisie parmi SEQ ID NO :1, des analogues de celle-ci, ou un fragment de celle-ci.
PCT/FR2007/051732 2006-07-26 2007-07-26 Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique WO2008012476A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0653130A FR2904223B1 (fr) 2006-07-26 2006-07-26 Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique
FR0653130 2006-07-26
US84864306P 2006-10-03 2006-10-03
US60/848,643 2006-10-03

Publications (2)

Publication Number Publication Date
WO2008012476A2 WO2008012476A2 (fr) 2008-01-31
WO2008012476A3 true WO2008012476A3 (fr) 2008-05-22

Family

ID=38981826

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/051732 WO2008012476A2 (fr) 2006-07-26 2007-07-26 Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique

Country Status (1)

Country Link
WO (1) WO2008012476A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI455728B (zh) * 2010-01-14 2014-10-11 Colgate Palmolive Co 牙劑組成物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474770A (en) * 1988-12-06 1995-12-12 Centre Regional De Transfusion Sanguine De Lille Biological support for cell cultures constituted by plasma proteins coagulated by thrombin, its use in the preparation of keratocyte cultures, their recovery and their transport for therapeutic purposes
DE19649098A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Proteasen
WO2000009709A2 (fr) * 1998-08-10 2000-02-24 Incyte Pharmaceuticals, Inc. Proteases et proteines associees
WO2001088157A2 (fr) * 2000-05-16 2001-11-22 Millennium Pharmaceuticals, Inc. Methodes de traitement avec 17906 et utilisations de celles-ci
US20040077001A1 (en) * 2002-08-02 2004-04-22 Millennium Pharmaceuticals Inc. Use for carboxypeptidase-A4 in the diagnosis and treatment of metabolic disorders
US20050112150A1 (en) * 1997-03-28 2005-05-26 Societe L'oreal S.A. Polypeptide expressed in the horny layer of the epidermis and its use

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474770A (en) * 1988-12-06 1995-12-12 Centre Regional De Transfusion Sanguine De Lille Biological support for cell cultures constituted by plasma proteins coagulated by thrombin, its use in the preparation of keratocyte cultures, their recovery and their transport for therapeutic purposes
DE19649098A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Proteasen
US20050112150A1 (en) * 1997-03-28 2005-05-26 Societe L'oreal S.A. Polypeptide expressed in the horny layer of the epidermis and its use
WO2000009709A2 (fr) * 1998-08-10 2000-02-24 Incyte Pharmaceuticals, Inc. Proteases et proteines associees
WO2001088157A2 (fr) * 2000-05-16 2001-11-22 Millennium Pharmaceuticals, Inc. Methodes de traitement avec 17906 et utilisations de celles-ci
US20040077001A1 (en) * 2002-08-02 2004-04-22 Millennium Pharmaceuticals Inc. Use for carboxypeptidase-A4 in the diagnosis and treatment of metabolic disorders

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 10 October 2003 (2003-10-10), "Human secreted polypeptide PRO1339, SEQ ID NO:308.", XP002472782, retrieved from EBI accession no. GSP:ABM35472 Database accession no. ABM35472 *
DATABASE Geneseq [online] 13 October 2003 (2003-10-13), "Human PRO polypeptide #154.", XP002428742, retrieved from EBI accession no. GSP:ABO52456 Database accession no. ABO52456 *
DATABASE Geneseq [online] 13 September 2003 (2003-09-13), "Human secreted/transmembrane protein (PRO) #154.", XP002428740, retrieved from EBI accession no. GSP:ABO27963 Database accession no. ABO27963 *
DATABASE Geneseq [online] 6 November 2003 (2003-11-06), "Human secreted polypeptide PRO1339-encoding cDNA, SEQ ID NO:307.", XP002428739, retrieved from EBI accession no. GSN:ACF75304 Database accession no. ACF75304 *

Also Published As

Publication number Publication date
WO2008012476A2 (fr) 2008-01-31

Similar Documents

Publication Publication Date Title
WO2005023866A3 (fr) Peptides permettant d'inhiber l'activation du complement
WO2009068627A3 (fr) Séquences d'acides aminés dirigés contre des cytokines hétérodimères et/ou leurs récepteurs et polypeptides les comprenant
WO2004103390A3 (fr) Agents therapeutiques comprenant des analogues stables de peptides et de polypeptides
EP2455460A3 (fr) Variantes de lipase pour utilisation pharmaceutique
EP3533461A3 (fr) Peptides dérivés de prame et compositions immunogènes les comportant
IL180101A (en) Isolated peptides, peptide complex / mhc class – i, peptide-encoded nucleic acid sequences, immune-containing peptides or nucleic acid sequences and their use in drug preparation
WO2008142164A3 (fr) Séquences d'acides aminés dirigées contre rank-l et polypeptides comprenant ces dernières, destinés au traitement de maladies et affections osseuses
WO2007104529A3 (fr) Séquences d'acides aminés dirigées contre il-6 et polypeptides incluant lesdites séquences dans le traitement de maladies et de troubles associés au signalement faisant intervenir il-6
WO2005115306A3 (fr) Polypeptide liant la keratine
WO2009018126A3 (fr) Peptides associés à du collagène et leurs utilisations
EP2428222A3 (fr) Combinaisons de peptide de vaccin contre l'allergie aux chats
WO2008113515A3 (fr) Antagonistes sélectifs de hutnfr1
WO2008093058A3 (fr) Peptides et leur utilisation
WO2007087053A3 (fr) Compositions à base de variantes de bmp-7, procédés et utilisations
WO2009064366A3 (fr) Procédés et compositions pour un marquage protéique à l'aide d'acide lipoïque ligases
WO2005121328A3 (fr) Methode permettant d'ameliorer un etat inflammatoire de la peau
WO2007100874A3 (fr) Compositions comprenant des peptides avec des acides aminés non naturels et leurs procédés d'utilisation
WO2008047370A3 (fr) Compositions et méthodes permettant d'induire l'angiogenèse
WO2010011994A3 (fr) Polypeptides et leurs utilisations
WO2006016172A3 (fr) Glycoproteine de surface
WO2006122971A3 (fr) Traitement de maladies a l'aide d'un systeme d'expression regulee, ameliore
WO2005072766A3 (fr) Peptides se liant aux proteines hsp90
WO2005019259A3 (fr) Variants de l'antagoniste du recepteur d'interleukine-1: compositions et utilisations correspondantes
WO2006043060A3 (fr) Proteine contenant le domaine mam
WO2008012476A3 (fr) Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07823648

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07823648

Country of ref document: EP

Kind code of ref document: A2